Sign in

Dylan Bieber

Vice President and Equity Research Analyst at William Blair Investment Management, LLC

Dylan Bieber is a Vice President and Equity Research Analyst at William Blair, specializing in biotechnology sector research with a focus on innovative therapeutics and life sciences companies. He covers a range of prominent biotech firms but detailed lists of companies and public performance metrics such as success rates or analyst rankings are not currently available. Bieber began his career in equity research after obtaining relevant professional licenses and has developed expertise in scientific and financial analysis; he joined William Blair with prior experience likely in the biopharmaceutical industry or equity research, though specifics are undisclosed. He holds FINRA securities licenses and is recognized for his analytical proficiency and sector knowledge within the biotechnology space.

Dylan Bieber's questions to Karooooo (KARO) leadership

Question · Q2 2026

Dylan Bieber from William Blair inquired about the impact of safety adoption and expansion on Karooooo's acceleration, specifically regarding subscriber additions, touch rates on newer offerings, customer willingness to adopt multiple products upfront, and the supporting health in the ARPU growth algorithm. He also asked about maintaining healthy unit economics while adding capacity across territories, new REP/REMP contribution, and the current state of sales capacity versus demand. Finally, he sought insight into the drivers of momentum in the South African market and the opportunity for multiple product cross-sell outside of South Africa.

Answer

Zak Calisto, Founder and Group CEO, explained that group ARPU grew by 4%, with an initial target of 10% for South Africa, which is now on track. He identified the primary bottleneck as the ability to build sufficient teams for onboarding new customers and cross-selling new products, noting that demand currently exceeds delivery capacity. For South Africa, he attributed momentum to the recent move into a new building, enabling faster recruitment and team building for new customer acquisitions and cross-selling. He also mentioned the potential for AI to alleviate pressure on staffing by reallocating jobs.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts